The Palmer Foundation

1st International Ivermectin for Covid Summit – Part 1

Source: Trial Site News

video

TrialSite hosted the first international Ivermectin for Covid Summit webinar on Sunday, May 23rd 2021. The event was widely attended with medical experts presenting from around the world to a global audience of interested parties in the thousands. The event was simultaneously broadcast live on YouTube.

With a mission to bring transparency and accessibility to clinical research TrialSite continues to track repurposed drugs as a potential option for COVID-19 along with vaccines, novel therapeutics and other measures.

PART 1

  • Introduction of speakers
  • Introduction – Dr. Martin Gill (2:00)
  • Welcome – Daniel O’Connor (5:37)
  • Ivermectin use in Zimbabwe – Dr. Jackie Stone (9:20)
  • Introduction to Dr. Sabine Hazan (22:50)
  • Early to treat, early to cure – Dr. Sabine Hazan (26:10)
  • Introduction to Dr. David Scheim (36:45)
  • Ivermectin for COVID-19 treatment in Peru – Dr. David Scheim (37:40)
  • Introduction to Dr. Jennifer Hibberd (50:00)
  • World data – Dr. Jennifer Hibberd (51:00)
  • Introduction to Dr. Lucy Kerr (1:03:00)
  • Ivermectin as a prophylaxis and treatment – Dr. Lucy Kerr (1:05:22)

PART 2

1st International Ivermectin for Covid Summit – Part 2

  • Introduction to Dr. Kylie M. Wagstaff (1:17:30)
  • In-vitro investigations of Ivermectin – Dr. Kylie M. Wagstaff (1:18:30)
  • Introduction to Dr. Tess Lawrie (1:34:25)
  • Sharing evidence on Ivermectin – Dr. Tess Lawrie (1:47:52)
  • Questions to the panel (1:48:20)
  • Closing keynote – Dr. Colleen Aldous





Related: 1st International Ivermectin for Covid Summit – Part 2

Interview with Zimbabwe’s Dr. Jackie Stone: COVID-19 Infection & DEATH RATES PLUMMET Post MCAZ green light for Ivermectin Use

Dr Pierre Kory Talks Ivermectin Success – Benefits Ricochet Around the World

Dr Tess Lawrie’s Powerful Closing Address at the International Ivermectin for Covid Conference​

Ivermectin for Covid-19 evidence update

NIH to Launch Massive ACTIV-6 Phase 3 Clinical Study Investigating Repurposed Drugs & Ivermectin May be on the List

Studies and global announcements

new

COVID-19 survivors

Global hydroxychloroquine timeline of events

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Explore more

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »
30/11/2021

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »
24/11/2021
Share on facebook
Facebook
Share on twitter
Twitter

Copyright 2020 © The Palmer Foundation